134 related articles for article (PubMed ID: 18647153)
1. Adrenal response to adrenocorticotropic hormone in dogs before and after surgical attenuation of a single congenital portosystemic shunt.
Holford AL; Tobias KM; Bartges JW; Johnson BM
J Vet Intern Med; 2008; 22(4):832-8. PubMed ID: 18647153
[TBL] [Abstract][Full Text] [Related]
2. Association of portovenographic findings with outcome in dogs receiving surgical treatment for single congenital portosystemic shunts: 45 cases (2000-2004).
Lee KC; Lipscomb VJ; Lamb CR; Gregory SP; Guitian J; Brockman DJ
J Am Vet Med Assoc; 2006 Oct; 229(7):1122-9. PubMed ID: 17014361
[TBL] [Abstract][Full Text] [Related]
3. Markers of hepatic regeneration associated with surgical attenuation of congenital portosystemic shunts in dogs.
Tivers MS; Lipscomb VJ; Smith KC; Wheeler-Jones CP; House AK
Vet J; 2014 May; 200(2):305-11. PubMed ID: 24662025
[TBL] [Abstract][Full Text] [Related]
4. Association between hepatic histopathologic lesions and clinical findings in dogs undergoing surgical attenuation of a congenital portosystemic shunt: 38 cases (2000-2004).
Lee KC; Winstanley A; House JV; Lipscomb V; Lamb C; Gregory S; Jalan R; Mookerjee RP; Brockman DJ
J Am Vet Med Assoc; 2011 Sep; 239(5):638-45. PubMed ID: 21879964
[TBL] [Abstract][Full Text] [Related]
5. Liver size, bodyweight, and tolerance to acute complete occlusion of congenital extrahepatic portosystemic shunts in dogs.
Doran IP; Barr FJ; Hotston Moore A; Knowles TG; Holt PE
Vet Surg; 2008 Oct; 37(7):656-62. PubMed ID: 19134088
[TBL] [Abstract][Full Text] [Related]
6. Incidence and risk factors for neurological signs after attenuation of single congenital portosystemic shunts in 253 dogs.
Strickland R; Tivers MS; Adamantos SE; Harcourt-Brown TR; Fowkes RC; Lipscomb VJ
Vet Surg; 2018 Aug; 47(6):745-755. PubMed ID: 30084495
[TBL] [Abstract][Full Text] [Related]
7. Endogenous benzodiazepine activity in the peripheral and portal blood of dogs with congenital portosystemic shunts.
Aronson LR; Gacad RC; Kaminsky-Russ K; Gregory CR; Mullen KD
Vet Surg; 1997; 26(3):189-94. PubMed ID: 9150556
[TBL] [Abstract][Full Text] [Related]
8. Congenital portosystemic shunts in dogs: 46 cases (1979-1986).
Johnson CA; Armstrong PJ; Hauptman JG
J Am Vet Med Assoc; 1987 Dec; 191(11):1478-83. PubMed ID: 3693002
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor (VEGF) and VEGF receptor expression in biopsy samples of liver from dogs with congenital portosystemic shunts.
Tivers MS; Lipscomb VJ; Scase TJ; Priestnall SL; House AK; Gates H; Wheeler-Jones CP; Smith KC
J Comp Pathol; 2012 Jul; 147(1):55-61. PubMed ID: 21996035
[TBL] [Abstract][Full Text] [Related]
10. Hepatic hepcidin gene expression in dogs with a congenital portosystemic shunt.
Frowde PE; Gow AG; Burton CA; Powell R; Lipscomb VJ; House AK; Mellanby RJ; Tivers MS
J Vet Intern Med; 2014; 28(4):1203-5. PubMed ID: 24962818
[TBL] [Abstract][Full Text] [Related]
11. Comparison of survival after surgical or medical treatment in dogs with a congenital portosystemic shunt.
Greenhalgh SN; Dunning MD; McKinley TJ; Goodfellow MR; Kelman KR; Freitag T; O'Neill EJ; Hall EJ; Watson PJ; Jeffery ND
J Am Vet Med Assoc; 2010 Jun; 236(11):1215-20. PubMed ID: 20513200
[TBL] [Abstract][Full Text] [Related]
12. Use of compounded adrenocorticotropic hormone (ACTH) for adrenal function testing in dogs.
Kemppainen RJ; Behrend EN; Busch KA
J Am Anim Hosp Assoc; 2005; 41(6):368-72. PubMed ID: 16267060
[TBL] [Abstract][Full Text] [Related]
13. Hemostatic profiles in 39 dogs with congenital portosystemic shunts.
Niles JD; Williams JM; Cripps PJ
Vet Surg; 2001; 30(1):97-104. PubMed ID: 11172465
[TBL] [Abstract][Full Text] [Related]
14. Thromboelastographic evaluation of dogs with congenital portosystemic shunts.
Kelley D; Lester C; DeLaforcade A; Webster CR
J Vet Intern Med; 2013; 27(5):1262-7. PubMed ID: 23815243
[TBL] [Abstract][Full Text] [Related]
15. Adrenal response to the low dose ACTH stimulation test and the cortisol-to-adrenocorticotrophic hormone ratio in canine babesiosis.
Schoeman JP; Herrtage ME
Vet Parasitol; 2008 Jul; 154(3-4):205-13. PubMed ID: 18468798
[TBL] [Abstract][Full Text] [Related]
16. Effects of single intravenously administered doses of dexamethasone on response to the adrenocorticotropic hormone stimulation test in dogs.
Kemppainen RJ; Sartin JL; Peterson ME
Am J Vet Res; 1989 Nov; 50(11):1914-7. PubMed ID: 2559631
[TBL] [Abstract][Full Text] [Related]
17. Hepatic volume measurements in dogs with extrahepatic congenital portosystemic shunts before and after surgical attenuation.
Kummeling A; Vrakking DJ; Rothuizen J; Gerritsen KM; van Sluijs FJ
J Vet Intern Med; 2010; 24(1):114-9. PubMed ID: 20391636
[TBL] [Abstract][Full Text] [Related]
18. Serum hyaluronic acid in dogs with congenital portosystemic shunts.
Seki M; Asano K; Sakai M; Kanno N; Teshima K; Edamura K; Tanaka S
J Small Anim Pract; 2010 May; 51(5):260-3. PubMed ID: 20402843
[TBL] [Abstract][Full Text] [Related]
19. Association of mesenteric portovenographic findings with outcome in cats receiving surgical treatment for single congenital portosystemic shunts.
Lipscomb VJ; Lee KC; Lamb CR; Brockman DJ
J Am Vet Med Assoc; 2009 Jan; 234(2):221-8. PubMed ID: 19210240
[TBL] [Abstract][Full Text] [Related]
20. Use of transcolonic portal scintigraphy to monitor blood flow and progressive postoperative attenuation of partially ligated single extrahepatic portosystemic shunts in dogs.
Van Vechten BJ; Komtebedde J; Koblik PD
J Am Vet Med Assoc; 1994 Jun; 204(11):1770-4. PubMed ID: 8063597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
